RNA interference suppression of neurodegenerative diseases and methods of use thereof
US9169483B2 · kind B2 · utility
20Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2013 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Jul 2, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.